• Cold Chain Shipping: Why Pharmacies Struggle and How to Strengthen Compliance

    Cold Chain Shipping: Why Pharmacies Struggle and How to Strengthen Compliance
    figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }Credit: Grispb – stock.adobe.com.By Karen Spano, RPh, HDDPAcross pharmacy settings—from independent and hospital pharmacies to large nati
  • New URAC Accreditation Offers Path to AI Implementation With Oversight

    New URAC Accreditation Offers Path to AI Implementation With Oversight
    Originally published by our sister publication Specialty Pharmacy ContinuumBy Marcus A. BanksThis summer, URAC introduced its Health Care AI Accreditation to establish standards for responsible deployment of artificial intelligence. A speaker from one of the first recipients of the new accreditation discussed how AI can, with guardrails, improve pharmacy operations and patient experience at the National Association of Specialty Pharmacy’s inSPire2026 meeting, in National Harbor, Maryland.f
  • What to Know About Bixlenvo for HIV

    What to Know About Bixlenvo for HIV
    By Meaghan Lee Callaghan What do you know about the newly approved HIV combination drug bictegravir/lenacapavir (Bixlenvo, Gilead)?Following the new FDA approval, Onyema Ogbuagu, MBBCh, MD, a professor at Yale University, in New Haven, sat down with Infectious Disease Special Edition to talk about the drug. Dr. Ogbuagu, who is also the director of the Yale Antivirals and Vaccines Research Program (formerly HIV Clinical Trials program), should know best—he was a study investigator

Follow @newsl_pharmacy on Twitter!